These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 20648416)
41. [Repetition of corticoid treatment for fetal lung maturation: clinical and experimental scientific data]. Schmitz T; Goffinet F; Jarreau PH; Moriette G; Cabrol D J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):458-68. PubMed ID: 11011275 [TBL] [Abstract][Full Text] [Related]
42. Antenatal corticosteroids: a retrospective cohort study on timing, indications and neonatal outcome. Frändberg J; Sandblom J; Bruschettini M; Maršál K; Kristensen K Acta Obstet Gynecol Scand; 2018 May; 97(5):591-597. PubMed ID: 29360141 [TBL] [Abstract][Full Text] [Related]
43. Antenatal Corticosteroids and Outcomes of Small-for-Gestational-Age Neonates. Melamed N; Pittini A; Barrett J; Shah J; Yoon EW; Lemyre B; Lee SK; Murphy KE; Shah PS; Obstet Gynecol; 2016 Nov; 128(5):1001-1008. PubMed ID: 27741177 [TBL] [Abstract][Full Text] [Related]
44. We Should Proceed With Caution When It Comes to Antenatal Corticosteroids After 34 Weeks. Nowik CM; Davies GA; Smith GN J Obstet Gynaecol Can; 2017 Jan; 39(1):49-51. PubMed ID: 28062023 [TBL] [Abstract][Full Text] [Related]
45. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study]. Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029 [TBL] [Abstract][Full Text] [Related]
46. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks]. Kinalski M; Sledziewski A; Kretowski A Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922 [TBL] [Abstract][Full Text] [Related]
47. Should antenatal corticosteroids be considered in women with gestational diabetes before planned late gestation caesarean section. Paul R; Murugesh C; Chepulis L; Tamatea J; Wolmarans L Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):463-466. PubMed ID: 30773614 [TBL] [Abstract][Full Text] [Related]
49. Antenatal corticosteroids prior to 24 weeks' gestation and neonatal outcome of extremely low birth weight infants. Abbasi S; Oxford C; Gerdes J; Sehdev H; Ludmir J Am J Perinatol; 2010 Jan; 27(1):61-6. PubMed ID: 19544249 [TBL] [Abstract][Full Text] [Related]
50. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Ventolini G; Neiger R; Mathews L; Adragna N; Belcastro M Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800 [TBL] [Abstract][Full Text] [Related]
51. [Repeat doses of prenatal corticosteroids for women at risk of preterm birth: a difficult consensus]. Guilherme R; Renaud C; Dommergues M; Mitanchez D J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):459-68. PubMed ID: 19473782 [TBL] [Abstract][Full Text] [Related]
52. Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes. Faucett AM; Metz TD; DeWitt PE; Gibbs RS Am J Obstet Gynecol; 2016 Feb; 214(2):287.e1-287.e5. PubMed ID: 26435047 [TBL] [Abstract][Full Text] [Related]
53. Multiple courses of antenatal corticosteroids: a systematic review and meta-analysis. Aghajafari F; Murphy K; Willan A; Ohlsson A; Amankwah K; Matthews S; Hannah M Am J Obstet Gynecol; 2001 Nov; 185(5):1073-80. PubMed ID: 11717636 [TBL] [Abstract][Full Text] [Related]
54. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465 [TBL] [Abstract][Full Text] [Related]
55. Multiple courses of antenatal corticosteroids are associated with early severe lung disease in preterm neonates. Banks BA; Macones G; Cnaan A; Merrill JD; Ballard PL; Ballard RA; J Perinatol; 2002 Mar; 22(2):101-7. PubMed ID: 11896513 [TBL] [Abstract][Full Text] [Related]
56. Controversies in antenatal corticosteroid treatment. Thevathasan I; Said JM Prenat Diagn; 2020 Aug; 40(9):1138-1149. PubMed ID: 32157719 [TBL] [Abstract][Full Text] [Related]
58. Perinatal care at the limit of viability between 22 and 26 completed weeks of gestation in Switzerland. 2011 revision of the Swiss recommendations. Berger TM; Bernet V; El Alama S; Fauchère JC; Hösli I; Irion O; Kind C; Latal B; Nelle M; Pfister RE; Surbek D; Truttmann AC; Wisser J; Zimmermann R Swiss Med Wkly; 2011; 141():w13280. PubMed ID: 22009720 [TBL] [Abstract][Full Text] [Related]
59. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. Mori R; Kusuda S; Fujimura M; J Pediatr; 2011 Jul; 159(1):110-114.e1. PubMed ID: 21334006 [TBL] [Abstract][Full Text] [Related]
60. Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion. Sinclair JC Am J Obstet Gynecol; 1995 Jul; 173(1):335-44. PubMed ID: 7631714 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]